Not Brian here, but a couple cents to toss in. I thought that Wilke (sp?) was attorney for Wanderport in matters of representation to the OTC market. The statement of authorized shares answers, partly, but does not outline how. Read the last sentence (from the Q2 unaudited filing)
Again, that matter comes down to with what Robert would align. Seems that would be the place to start, as going in blind on that part could be just so much wasted effort should he vote it down (with his 62.25% holding of issued).
I have had some communication with Mr. Wilke but not in the matters you've mentioned. Others are working on some of these details though. Also, I'm not the leader. I'm just being vocal with my opinions and what I believe we need to position the company for the best possible outcome.